Neurogene's market cap is currently $363.16M. The company's EPS TTM is $-4.493; its P/E ratio is ―; Neurogene is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -3.26M	$ -3.20M	$ -2.28M	$ -1.82M	$ -340.00K
Operating Income	$ -55.58M	$ -56.52M	$ -50.53M	$ -41.55M	$ -24.44M
EBITDA	$ -52.29M	$ -51.99M	$ -49.59M	$ -31.46M	$ -69.10M
Net Income	$ -36.32M	$ -55.19M	$ -50.52M	$ -33.28M	$ -69.44M
Balance Sheet
Cash & Short-Term Investments	$ 197.16M	$ 82.02M	$ 70.54M	$ 192.56M	$ 143.09M
Total Assets	$ 222.57M	$ 109.27M	$ 101.49M	$ 210.52M	$ 147.02M
Total Debt	$ 16.25M	$ 4.69M	$ 5.21M	$ 12.12M	$ 1.21M
Net Debt	$ -131.96M	$ -77.33M	$ -65.33M	$ -180.43M	$ -141.88M
Total Liabilities	$ 36.55M	$ 255.00M	$ 193.36M	$ 19.30M	$ 5.34M
Stockholders' Equity	$ 186.02M	$ -145.74M	$ -91.88M	$ 191.22M	$ 141.69M
Cash Flow
Free Cash Flow	$ -51.74M	$ -55.05M	$ -64.77M	$ -26.79M	$ -16.27M
Operating Cash Flow	$ -51.42M	$ -52.82M	$ -46.40M	$ -24.57M	$ -15.39M
Investing Cash Flow	$ 25.64M	$ -2.23M	$ -18.37M	$ -2.22M	$ -688.00K
Financing Cash Flow	$ 92.48M	$ 66.53M	$ 51.06M	$ 77.14M	$ 82.24M

Currency in USD

Neurogene Earnings and Revenue History

Income Statement >

Neurogene Debt to Assets

Balance Sheet >

Neurogene Cash Flow

Cash Flow >

Neurogene Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing